ARS Pharmaceuticals
SPRY
#8299
Rank
A$0.44 B
Marketcap
A$4.47
Share price
-11.90%
Change (1 day)
-61.95%
Change (1 year)

EPS for ARS Pharmaceuticals (SPRY)

EPS in 2026 (TTM): A-$3.28

According to ARS Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$3.35. In 2025 the company made an earnings per share (EPS) of A-$2.63 a decrease over its 2024 EPS that were of A$0.12.

EPS history for ARS Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.2824.72%
2025A-$2.63-2275%
2024A$0.12-114.04%
2023A-$0.86-34.48%
2022A-$1.31303%
2021A-$0.331800.68%
2020A-$0.01716